Page 7 - மருந்து ஆம்ப் சாதனம் வளர்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து ஆம்ப் சாதனம் வளர்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து ஆம்ப் சாதனம் வளர்ச்சி Today - Breaking & Trending Today

Factbox: Companies developing mRNA treatments and vaccines

By Reuters Staff
3 Min Read
(Reuters) - The United States has cleared the use of vaccines using messenger RNA (mRNA) to create an immune response from Moderna Inc and partners BioNTech SE and Pfizer Inc, boosting confidence in the novel technology.
FILE PHOTO: U.S. President Joe Biden is seen as he tours a Pfizer manufacturing plant producing the coronavirus disease (COVID-19) vaccine in Kalamazoo, Michigan, U.S., February 19, 2021. REUTERS/Tom Brenner/File Photo
The following is a list of companies also using mRNA technology to develop treatments and vaccines for diseases including COVID-19:
TRANSLATE BIO/SANOFI Translate Bio Inc’s lead drug is a cystic fibrosis treatment being tested in early-to-mid stage clinical trials. It is also developing mRNA vaccines for infectious diseases, including COVID-19 and flu, along with Sanofi SA. CUREVAC/GLAXOSMITHKLINE ....

United States , Manas Mishra , Vertex Pharmaceuticals Inc , Merck Co , Gritstone Oncology Inc , Melinda Gates Foundation , Gilead Sciences Inc , Astrazeneca Plc , Pfizer Inc , Moderna Inc , Thomson Reuters Trust Principles , Us National Laboratory , Bio Inc , Arcturus Therapeutics Inc , Oncology Inc , Therapeutics Inc , Thomson Reuters Trust , Corona Virus , Content Produced In Bangalore , Company News , Products Services , Drug Amp Device Development , Healthcare Trbc Level 1 , Medical Regulation , Biotechnology Amp Medical Research Trbc Level 4 , Pharmaceuticals Amp Medical Research Trbc Level 2 ,

EU regulator to meet on Thursday to discuss AstraZeneca vaccine

The European medicines regulator said on Monday it would hold a meeting this week on the information gathered into whether the AstraZeneca COVID-19 vaccine contributed to thromboembolic events in those inoculated. ....

Yadarisa Shabong , Shounak Dasgupta , Thomson Reuters Trust Principles , European Medicines Agency , Thomson Reuters Trust , Corona Virus , Content Produced In Bangalore , Company News , Drug Amp Device Development , European Union , United Kingdom , General News , Healthcare Trbc Level 1 , Medical Regulation , Major News , Pharmaceuticals Nec Trbc Level 5 , Corporate Market Regulation , Reuters Top News , ஷ்ௌுனாக் தாஸ்குப்தா , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை , கொரோனா வைரஸ் , உள்ளடக்கம் ப்ரொட்யூஸ்ட் இல் பெங்களூர் , நிறுவனம் செய்தி , மருந்து ஆம்ப் சாதனம் வளர்ச்சி , ஐரோப்பிய தொழிற்சங்கம் ,

Exclusive: AbbVie in talks to sell $5 billion women's drugs portfolio - sources

U.S. drugmaker AbbVie Inc is in discussions to sell a roughly $5 billion portfolio of women's drugs acquired last year through its $63 billion purchase of Botox maker Allergan Plc, sources familiar with the matter told Reuters. ....

City Of , United Kingdom , Loestrin Fe , Richard Chang , Pamela Barbaglia , Rebecca Spalding , Arno Schuetze , Robert Stewart , Thomson Reuters Trust Principles , Morgan Stanley , Allergan Plc , Abbvie Inc , Teva Pharmaceutical Industries Ltd , Teva Pharmaceutical Industries , Chief Executive Robert Stewart , Thomson Reuters Trust , Womens Health , Company News , Drug Amp Device Development , Generic Pharmaceuticals Trbc Level 5 , Enterprise Reporting , Health Medicine , Healthcare Trbc Level 1 , Investment Banking Trbc Level 5 , Investment Banking Amp Brokerage Services Trbc Level 4 , Investment Banking Amp Brokerage Services Nec Trbc Level 5 ,

EU drug regulator outlines plan to fast track variant-modified COVID vaccines

Europe's medicines regulator said on Thursday it has issued new guidance for drug makers that modify their COVID-19 vaccines to protect against variants of the virus to speed up the approval process. ....

South Africa , United Kingdom , Josephine Mason , Yadarisa Shabong , Arun Koyyur , Emilio Parodi , Thomson Reuters Trust Principles , European Medicines Agency , Thomson Reuters Trust , Corona Virus , Content Produced In Bangalore , Company News , Drug Amp Device Development , European Union , General News , Health Medicine , Healthcare Trbc Level 1 , Medical Regulation , Biotechnology Amp Medical Research Trbc Level 4 , Biotechnology Amp Medical Research Nec Trbc Level 5 , Major News , Pharmaceuticals Nec Trbc Level 5 , Pharmaceuticals Amp Medical Research Trbc Level 2 , Corporate Market Regulation , Science Technology , Reuters Top News ,

EXPLAINER-Activists, drug groups in waiver war over COVID-19 shot patents

A World Trade Organization (WTO) council is discussing a proposal by India and South Africa that COVID-19 vaccine and other medical patents be suspended to speed up technology transfers to manufacturers with spare production capacity. ....

United States , United Kingdom , South Africa , Bruxelles Capitale , Richard Hatchett , Ludwig Burger , Phil Blenkinsop , Tedros Adhanom Ghebreyesus , Josephine Mason , Nick Macfie , John Miller , Stephanie Nebehay , Ngozi Okonjo Iweala , Thomson Reuters Trust Principles , Countries Vaccine Manufacturers Network , World Health Organization , World Trade Organization , Us Chamber , Coalition For Epidemic Preparedness Innovations , A World Trade Organization , Oxford University Sarah Gilbert , Related Aspects , Intellectual Property , World Trade , Doctors Without Borders , Tedros Adhanom ,